瑞康医药 (002589.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(瑞康医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 2,025,130,031.902,006,904,829.612,073,027,669.161,414,560,934.873,345,646,405.503,457,573,370.624,093,497,042.67
 营业收入(元) 2,025,130,031.902,006,904,829.612,073,027,669.161,414,560,934.873,345,646,405.503,457,573,370.624,093,497,042.67
二、营业总成本(元) 2,026,222,485.842,102,077,797.752,081,916,966.471,883,478,147.053,390,031,881.013,393,930,497.473,955,744,878.12
 营业成本(元) 1,739,857,175.661,793,374,926.301,753,394,409.581,572,250,196.632,834,796,805.772,852,583,605.223,379,572,423.41
 研发费用(元) 3,912,790.213,417,561.922,846,655.1412,318,111.363,157,265.602,923,734.204,278,536.62
 营业税金及附加(元) 19,901,711.217,897,948.359,464,728.678,932,963.4711,215,956.9813,596,902.3718,381,380.18
 销售费用(元) 116,166,042.82157,029,469.72102,338,007.7949,874,315.15260,035,669.36257,884,595.18279,354,504.41
 管理费用(元) 115,635,496.54124,321,565.7194,926,386.03159,121,767.54193,476,805.33179,117,126.73168,194,467.64
 财务费用(元) 30,749,269.4016,036,325.75118,946,779.2680,980,792.9087,349,377.9787,824,533.77105,963,565.86
  其中:利息费用(元) 80,152,541.5144,968,502.06122,639,152.6065,647,453.6496,475,219.9490,473,166.00155,110,354.97
  其中:利息收入(元) 48,171,626.8129,775,546.7223,538,527.00-18,216,729.7313,700,160.0317,021,727.8771,463,463.72
 资产减值损失(元) ----217,935,977.75---
 信用减值损失(元) -12,899,408.939,351,912.0016,451,497.77-162,930,115.67-90,778,575.37-35,367,570.58-1,743,988.75
三、其他经营收益
 加:公允价值变动收益(元) -98,041,200.00-146,738,500.00-32,640,000.00-322,342,406.11-99,883,693.56--
 加:投资收益(元) 98,163,090.30265,060,673.0753,288,290.22-742,267,465.03256,773,870.034,378,716.21-2,897.98
 资产处置收益(元) 25,897.7548,396.112,668,716.19-5,373,446.61-568,301.97-2,102,667.727,049,110.05
 其他收益(元) 116,218.07-695,270.762,098,533.847,113,173.642,790,372.41-1,238,590.108,235,212.40
四、营业利润(元) -13,727,856.7531,854,242.2832,977,740.71-1,912,653,449.7123,948,196.0320,796,395.69151,289,600.27
 加:营业外收入(元) 1,628,030.061,794,648.751,192,715.93-2,460,765.411,244,656.981,670,767.48652,712.09
 减:营业外支出(元) 21,743,797.72-518,943.851,233,874.9513,221,159.634,867,493.414,370,415.115,940,609.28
五、利润总额(元) -33,843,624.4134,167,834.8832,936,581.69-1,928,335,374.7520,325,359.6018,096,748.06146,001,703.08
 减:所得税费用(元) -20,089,212.2622,564,851.172,953,133.65-43,500,039.5112,964,468.73-21,325,884.6347,422,544.83
六、净利润(元) -13,754,412.1511,602,983.7129,983,448.04-1,884,835,335.247,360,890.8739,422,632.6998,579,158.25
(一)按经营持续性分类
  持续经营净利润(元) -13,754,412.1511,602,983.7129,983,448.04-1,884,835,335.247,360,890.8739,422,632.6998,579,158.25
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -11,447,150.759,507,704.5821,159,565.23-1,892,736,805.572,094,083.7016,254,275.4042,736,596.17
  少数股东损益(元) -2,307,261.402,095,279.138,823,882.817,901,470.335,266,807.1723,168,357.2955,842,562.08
 扣除非经常性损益后的净利润(元) 8,242,407.50-109,013,051.70-4,256,424.09-783,357,389.08-148,043,792.09-34,586,196.3238,429,500.10
七、每股收益
 一、基本每股收益(元) -0.010.010.01-1.28-0.010.03
 二、稀释每股收益(元) -0.010.010.01-1.28-0.010.03
九、综合收益总额(元) -13,754,412.1511,602,983.7129,983,448.04-1,884,835,335.247,360,890.8739,422,632.6998,579,158.25
 归属于母公司所有者的综合收益总额(元) -11,447,150.759,507,704.5821,159,565.23-1,892,736,805.572,094,083.7016,254,275.4042,736,596.17
 归属于少数股东的综合收益总额(元) -2,307,261.402,095,279.138,823,882.817,901,470.335,266,807.1723,168,357.2955,842,562.08
公告日期 2023-10-312023-08-302023-04-292023-04-292022-10-312022-08-302022-04-30
审计意见(境内) 标准无保留意见

前瞻产业研究院